enGene Therapeutics, Inc. (ENGN)
7.23
-0.04
(-0.55%)
USD |
NASDAQ |
May 01, 16:00
7.23
0.00 (0.00%)
After-Hours: 18:59
enGene Therapeutics Total Liabilities (Quarterly) : 55.57M for Jan. 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Achieve Life Sciences, Inc. | 20.56M |
| Oncolytics Biotech, Inc. | 11.38M |
| Aurinia Pharmaceuticals, Inc. | 189.26M |
| Edesa Biotech, Inc. | 0.7562M |
| Lexaria Bioscience Corp. | 0.277M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 337.11M |
| Shareholders Equity (Quarterly) | 281.55M |
| Debt to Equity Ratio | 0.1189 |
| Current Ratio | 11.75 |
| Net Debt Paydown Yield | -0.26% |